Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(SAU: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Stories about
 
Pfizer Shrinks Its Drug Pipeline Amid R&D Cuts
March 01, 2011
In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world's largest pharmaceutical company announced large research... Read More
category Lipitor , research , pharmaceutical , and 24 more.
from DailyFinance.com
The Problem with Fast-Tracking Drug Approvals: Pharmas Fail to Follow Up
February 09, 2011
To get potentially lifesaving drugs to patients faster, the U.S. Food and Drug Administration is allowed to approve some drugs -- those that address unmet medical needs -- based on fewer trials than... Read More
category drug approval , GSK , cancer drugs , and 15 more.
from DailyFinance.com
2010 Was a Rough Year for Pharmaceutical Jobs; Will 2011 Be Better?
January 07, 2011
If you don't count the U.S. government and nonprofits, the pharmaceutical industry had the most job cuts last year. Mergers, acquisitions and major restructurings made pharma a much smaller and leaner... Read More
category big pharma , pharmaceutical stocks , MRK, PFE , and 13 more.
from DailyFinance.com
AstraZeneca's Brilinta Fails to Win FDA Approval
December 17, 2010
AstraZeneca failed to win FDA approval for its heart drug Brilinta, which the company -- facing a severe patent cliff -- has high hopes for. If approved, it could be a multibillion-dollar blockbuster.... Read More
category AZN , heart medications , pharmaceutical industry , and 13 more.
from DailyFinance.com
WikiLeaks: Did Pfizer Use Unethical Tactics to Evade a Clinical Trial Settlement?
December 10, 2010
According to the latest leaked U.S. diplomatic cables from WikiLeaks, Pfizer hired investigators to try to uncover evidence of corruption in order to pressure the Nigerian attorney general to drop the... Read More
category corruption , pfizer nigeria , nigerian , and 20 more.
from DailyFinance.com
Johnson & Johnson Launches Offer for Crucell
December 08, 2010
Johnson & Johnson has finally launched its bid for Dutch vaccine-maker Crucell -- as part of efforts to expand into the biotech market Continue reading Johnson & Johnson Launches Offer for Crucell... Read More
category JohnsonAndJohnsonjnj , pharmaceutical stocks , Johnson and Johnson JNJ , and 18 more.
from DailyFinance.com
FDA Panel Backs Orexigen's Diet Pill
December 07, 2010
After the U.S. Food and Drug Administration rejected two other weight-loss pills earlier this year, an advisory panel has recommended the approval of Orexigen Therapeutics's Contrave. If the FDA... Read More
category food and drug administration , pharmaceutical , OREX , and 18 more.
from DailyFinance.com
Novartis Halts Lung Cancer Drug Study
November 11, 2010
Novartis will discontinue studies of an experimental lung-cancer cancer drug because of disappointing trial results. Continue reading Novartis Halts Lung Cancer Drug Study Novartis Halts Lung Cancer... Read More
category NVS , generics , cancer , and 2 more.
from DailyFinance.com
Sanofi-Aventis to Cut 1,700 Jobs in the U.S.
October 08, 2010
Sanofi-Aventis ( SNY ) said Friday it plans to lay off 1,700 workers at its U.S. pharmaceutical operations, which amounts to about 25% of its U.S. workforce. The cutbacks are part of an ongoing... Read More
category layoffs , pharmaceutical industry , Sanofi/Aventis , and 7 more.
from DailyFinance.com
Legal Briefing: IRS and Justice Department Target More Rich Tax Cheats
July 07, 2010
Now that they are nearly done squeezing Swiss bank UBS for information about its wealthy tax-dodging clients, the IRS and the Justice Department are moving on to new tax fraud targets: Clients of... Read More
category Supreme Court , second amendment , merck , and 21 more.
from DailyFinance.com
InterMune Shares Soar After FDA Panel Backs Lung Disease Drug
March 09, 2010
InterMune shares soared over 60% after hours after it came closer to FDA approval of its experimental treatment for a fatal lung disease. An advisory panel voted to approve the drug despite... Read More
category drug approval , FDA , itmn , and 1 more.
from DailyFinance.com
Why American Industry Could Become Dangerous
February 23, 2010
In January 2010, the Supreme Court gave corporations unlimited power to spend money on political campaigns, effectively swaying politicians in their favor. But by doing this, Washington could become... Read More
category government , banking , TM , and 3 more.
from DailyFinance.com
Genzyme's bad year gets worse: Experimental kidney drug a no-go
November 18, 2009
DailyFinance : For Genzyme Corp (GENZ), this year seems to have been plagued with one piece of bad news after another. On Wednesday, the biotechnology company announced that it was dropping development... Read More
category food and drug administration , pharmaceutical , kidney , and 16 more.
from DailyFinance.com
Amgen's troubles keep compounding; Aranesp studies reveal greater risks
November 11, 2009
DailyFinance : It seems that when it comes to Aranesp, its blockbuster anemia drug, Amgen (AMGN) just can't catch a break, nor for that matter, create one. Recently, Amgen was hit with a double whammy... Read More
category bmy , aranesp , amgen , and 29 more.
from DailyFinance.com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here